{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:49:17Z","timestamp":1792669757005,"version":"4.5.0"},"reference-count":109,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001297","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:16:04Z","timestamp":1069366564000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density"],"prefix":"10.1002","volume":"2010","author":[{"given":"Jessica E","family":"Farmer","sequence":"first","affiliation":[{"name":"South Green Lodge 24 South Green Road Cambridge CB2 1RL UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Prentice","sequence":"additional","affiliation":[{"name":"Rosie Maternity Hospital; Department of Obstetrics and Gynaecology; Robinson Way Cambridge UK CB2 2SW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Breeze","sequence":"additional","affiliation":[{"name":"3 Crafts Way Highfields Caldecote Cambridge Cambridgeshire UK CB23 7ZP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaity","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Pennine Acute NHS Trust; Obstetrics & Gynaecology; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James MN","family":"Duffy","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' Hospital; Westiminster Bridge Road London UK SE1 7EH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Watson","sequence":"additional","affiliation":[{"name":"Tameside General Hospital; Tameside & Glossop Acute Services NHS Trust; Fountain Street Ashton-Under-Lyme Lancashire UK OL6 9RW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Pick","sequence":"additional","affiliation":[{"name":"Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,20]]},"reference":[{"key":"10.1002\/14651858.CD001297-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Aisaka K Nakagawa K Uesato T Miwa A Koshino T Ooka F Effectiveness of long term GnRH agonist administration for treatment of endometriosis combined with oestrogen-progestogen add back therapy XVI FIGO World Congress of Obstetrics and Gynaecology 2000","DOI":"10.1016\/S0020-7292(00)82576-X"},{"key":"10.1002\/14651858.CD001297-BIB0002|cit2","unstructured":"Chan CLK Soon SB Loh FH Devendra S Ng SC Ratnam SS Comparitive study of gestrinone, danazol and decapeptyl CR in the treatment of endometriosis 2nd International Scientific Meeting of the Royal College of Obstetricians , Hong Kong 1993 82"},{"issue":"12","key":"10.1002\/14651858.CD001297-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/oxfordjournals.humrep.a019199","article-title":"Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study","volume":"11","author":"Crosignani","year":"1996","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001297-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0015-0282(16)57593-1","article-title":"Depot leuprolide acetate versus danazol for the treatment of pelvic endometriosis: changes in vertebral bone mass and serum estrodiol and calcitonin","volume":"63","author":"Dawood","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0005|cit5","first-page":"410","article-title":"Bone mass in endometriosis patients treated with GnRH agonist implant or danazol","volume":"77","author":"Dodin","year":"1991","journal-title":"Obstetrics and Gynaecology"},{"issue":"supplement 10","key":"10.1002\/14651858.CD001297-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1471-0528.1994.tb13681.x","article-title":"Can hormone replacement therapy be used during medical therapy of endometriosis?","volume":"101","author":"Edmonds","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001297-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.1992.tb02338.x","article-title":"A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone","volume":"37","author":"Eldred","year":"1992","journal-title":"Clincal Endocrinology"},{"key":"10.1002\/14651858.CD001297-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Franke H Enschede K Van der Weijer P Pennings T Van der Mooren M Gonadotrophin-releasing hormone agonist plus add-back for the treatment of endometriosis. A prospective, randomized, placebo controlled, double blind trial XVI FIGO World Congress of Obstetrics and Gynaecology 2000","DOI":"10.1016\/S0020-7292(00)82571-0"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0015-0282(00)00690-7","article-title":"Gonadotrophin-releasing hormone agonist plus 'add-back' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double blind trial","volume":"74","author":"Franke","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"supplement 1","key":"10.1002\/14651858.CD001297-BIB0011|cit10","first-page":"S17","article-title":"Changes in bone mineral content following hormone treatment for endometriosis","volume":"50","author":"Fukushima","year":"1995","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1447-0756.1993.tb00389.x","article-title":"Hormone treatment related bone mineral content changes in Japanese women with endometriosis","volume":"19","author":"Fukushima","year":"1993","journal-title":"Asia-Oceania Journal of Obstetrics and Gynaecology"},{"issue":"supplement 1","key":"10.1002\/14651858.CD001297-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000052848","article-title":"Steroidal 'add-back' therapy in patients treated with GnRH agonists","volume":"45","author":"Freundl","year":"1998","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"47","key":"10.1002\/14651858.CD001297-BIB0014|cit13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000010059","article-title":"Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotrophin-releasing hormone agonists","volume":"1","author":"Gnoth","year":"1999","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0013|cit14","first-page":"32","article-title":"Effects of the add-back therapy on bone mineral density and pyridinium-crosslinks under central suppression by GnRH-agonists","volume":"76 Suppl","author":"G\u00f6dtke","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD001297-BIB0015|cit15","first-page":"406","article-title":"Gonadotrophin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomised controlled trial","volume":"42","author":"Gregoriou","year":"1997","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD001297-BIB0016|cit16","first-page":"343","article-title":"Nafarelin: a new medical therapy for endometriosis","volume":"323","author":"Henzl","year":"1990","journal-title":"Progress in Clinical and Biological Research"},{"issue":"Number 2","key":"10.1002\/14651858.CD001297-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(90)90432-7","article-title":"Efficacy and safety of nafarelin in the treatment of endometriosis","volume":"162","author":"Henzl","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(90)90432-7","article-title":"Efficacy and safety of nafarelin in the treatment of endometriosis","volume":"162","author":"Henzl","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0019|cit19","first-page":"343","article-title":"Nafarelin: A new medical therapy for endometriosis","volume":"323","author":"Henzl","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(90)90432-7","article-title":"Efficacy and safety of nafarelin in the treatment of endometriosis","volume":"162","author":"Henzl","year":"1990","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0021|cit21","first-page":"343","article-title":"Nafarelin: A new medical therapy for endometriosis","volume":"323","author":"Henzl","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001297-BIB0023|cit23","unstructured":"Surrey ES Hornstein MD Abstracts from ASRM\/CFAS Conjoint Annual Meeting Toronto, Canada 1999 80"},{"issue":"5 part 1","key":"10.1002\/14651858.CD001297-BIB0024|cit24","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0026|cit26","unstructured":"Surrey ES Hornstein MD Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis patients: long term follow-up of a 12 month clinical trial Abstracts from ASRM\/CFAS Conjoint Annual Meeting Toronto, Canada 1999 80"},{"issue":"5 part 1","key":"10.1002\/14651858.CD001297-BIB0027|cit27","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month atudy","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0029|cit29","unstructured":"Surrey ES Hornstein MD Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis patients: long term follow-up of a 12 month cinical trial Abstracts from ASRM\/CFAS Conjoint Annual Meeting Toronto, Canada 1999 80"},{"issue":"5 part 1","key":"10.1002\/14651858.CD001297-BIB0030|cit30","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0032|cit32","unstructured":"Surrey ES Hornstein MD Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis patients: long term follow-up of a 12 month clinical trial Abstracts from ASRM\/CFAS Conjoint Annual Meeting 1999 80"},{"issue":"5 part 1","key":"10.1002\/14651858.CD001297-BIB0033|cit33","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0015-0282(16)57779-6","article-title":"Gonadotrophin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis:a randomised controlled trial","volume":"64","author":"Howell","year":"1995","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001297-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000052978","article-title":"Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotrophin-releasing hormone agonists treatment in women with endometriosis","volume":"52","author":"Irahara","year":"2001","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"suppl 14","key":"10.1002\/14651858.CD001297-BIB0036|cit36","first-page":"15","article-title":"Should add-back therapy for endometriosis be deferred for optimal results?","volume":"103","author":"Kiesel","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (livial) on patients treated with the gonadotrophin releasing hormone agonist triptorelin (decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001297-BIB0038|cit38","first-page":"337","article-title":"Leuprolide Acetate for the Treatment of Endometriosis","volume":"323","author":"Miller","year":"1990","journal-title":"Progress in Clinical and Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial II. Assessment of safety","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis I. Efficacy results","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0041|cit41","first-page":"337","article-title":"Leuprolide acetate for the treatment of endometriosis","volume":"323","author":"Miller","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial II. Assessment of safety","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis I. Efficacy results","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0044|cit44","first-page":"337","article-title":"Leuprolide acetate for the treatment of endometriosis","volume":"323","author":"Miller","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial II. Assessment of safety","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometrisosis I. Efficacy results","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0047|cit47","first-page":"337","article-title":"Leuprolide acetate for the treatment of endometriosis","volume":"323","author":"Miller","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: A multicenter, double-blind randomized clinical trial II. Assessment of safety","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis I. Efficacy results","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"suppl 14","key":"10.1002\/14651858.CD001297-BIB0051|cit50","first-page":"14","article-title":"Add-back therapy in the treatment of endometriosis: The North American Experience","volume":"103","author":"Moghissi","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD001297-BIB0050|cit51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0015-0282(98)00086-7","article-title":"Goserelin acetate (zoladex) with or without hormone replacement therapy for the treatment of endometriosis","volume":"69","author":"Moghissi","year":"1998","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001297-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9378(96)70258-2","article-title":"A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment","volume":"175","author":"Mukherjee","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0053|cit53","first-page":"198","article-title":"Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol","volume":"82","author":"Rock","year":"1993","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002239900388","article-title":"Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment","volume":"62","author":"Borderie","year":"1998","journal-title":"Calcified Tissue International"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during gonadotrophin releasing hormone agonist treatment and the use of nasal calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD001297-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002239900388","article-title":"Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment","volume":"62","author":"Borderie","year":"1998","journal-title":"Calcified Tissue International"},{"key":"10.1002\/14651858.CD001297-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD001297-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s002239900388","article-title":"Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment","volume":"62","author":"Borderie","year":"1998","journal-title":"Calcified Tissue International"},{"key":"10.1002\/14651858.CD001297-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD001297-BIB0060|cit60","unstructured":"Seibel MJ Woitge HW Parviz M Sillem M Kiesel L Pfeilschifter J Medrogestone prevents accelerated bone turnover in GnRH analogue treated endometriosis Klinisches Labor 1996 1075 78"},{"key":"10.1002\/14651858.CD001297-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0029-1212129","article-title":"Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin","volume":"107","author":"Sillem","year":"1999","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"issue":"8","key":"10.1002\/14651858.CD001297-BIB0062|cit62","first-page":"2700","article-title":"Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","year":"1999","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD001297-BIB0063|cit63","first-page":"2700","article-title":"Use of vitamin K\u00b2 (menatetrenone) and 1,25 - dihydroxyvitamin D\u00b3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD001297-BIB0064|cit64","first-page":"2700","article-title":"Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","year":"1999","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1002\/14651858.CD001297-BIB0065|cit65","first-page":"2700","article-title":"Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","year":"1999","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0066|cit66","first-page":"558","article-title":"Reduction of vasomotor symptoms and bone mineral density loss with combined norethidrone and long-acting gonadotrophin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomised trial","volume":"75","author":"Surrey","year":"1992","journal-title":"Journal of Clincal Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001297-BIB0067|cit67","unstructured":"Vella A Brincat M Galea R Muscat Baron Y Skin thickness and bone density: effect of add-back therapy in women on GnRH analogues 27th British Congress of Obstetrics & Gynaecology, Dublin 1995 155"},{"issue":"6","key":"10.1002\/14651858.CD001297-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotrophin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicentre, randomized, double blind study","volume":"66","author":"The Gestrinone Italian Study Group","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"33","key":"10.1002\/14651858.CD001297-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1990.tb00501.x","article-title":"The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis","volume":"3","author":"Whitehouse","year":"1990","journal-title":"Clinical Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD001297-BIB0070|cit70","first-page":"413","article-title":"Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms","volume":"42","author":"Agarwal","year":"1997","journal-title":"Journal of Reproductive Medicine for the Obstetrician and Gynecologist"},{"key":"10.1002\/14651858.CD001297-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Agarwal SK The impact of 6 months GnRH agonist therapy for the treatment of endometriosis on bone mineral density: is there an age-related effect? Abstracts of the 15th Annual Meeting of the ESHRE, France Tours, France 1999 260","DOI":"10.1093\/humrep\/14.Suppl_3.260-a"},{"issue":"6","key":"10.1002\/14651858.CD001297-BIB0072|cit72","first-page":"431","article-title":"A randomised comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis","volume":"57","author":"Chang","year":"1996","journal-title":"Chinese Medical Journal (Taipei)"},{"key":"10.1002\/14651858.CD001297-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0028-2243(94)02016-8","article-title":"A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis","volume":"59","author":"Cirkel","year":"1995","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001297-BIB0074|cit74","unstructured":"Cirkel U Ochs H Schneider HPG GNRH analogue depot versus danazol in the treatment of endometriosis 3rd International Symposium on Gynaecological Endocrinology Geneva, Switzerland 1993 20"},{"issue":"12 suppl","key":"10.1002\/14651858.CD001297-BIB0075|cit75","first-page":"1025","article-title":"Clinical experience treating endometriosis with nafarelin","volume":"34","author":"Claesson","year":"1989","journal-title":"The Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(16)60782-3","article-title":"Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol","volume":"52","author":"Dawood","year":"1989","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9378(97)70504-0","article-title":"Clinical, endocrine and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis","volume":"176","author":"Dawood","year":"1997","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"24","key":"10.1002\/14651858.CD001297-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","article-title":"Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency","volume":"331","author":"Finkelstein","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0079|cit79","first-page":"1214","article-title":"Increases in bone mineral density after discontinuation of daily parathyroid hormone and gonadotrophin-releasing analog administration in women with endometriosis.","volume":"84","author":"Finkelstein","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD001297-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","article-title":"Prevention of estrogen deficiency-related bone loss with human parathyroid hormone","volume":"280","author":"Finkelstein","year":"1998","journal-title":"JAMA"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD001297-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-0528.1994.tb13680.x","article-title":"Goserelin (zoladex) and the skeleton","volume":"101","author":"Fogelman","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0082|cit82","first-page":"127","article-title":"Goserelin versus danazol in the treatment of endometriosis","volume":"18","author":"Giorgino","year":"1991","journal-title":"Clinical and Experimental Obstetrics and Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0083|cit83","first-page":"299","article-title":"Treatment of endometriosis with dienogest: preliminary report","volume":"72","author":"Kaminski","year":"2001","journal-title":"Ginekologia Polska"},{"issue":"9","key":"10.1002\/14651858.CD001297-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/humrep\/14.9.2371","article-title":"Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis","volume":"14","author":"Morgante","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001297-BIB0085|cit85","first-page":"30","article-title":"The effects of nafarelin therapy on hip and spine bone mineral density in endometriosis:a prospective, randomized, double-blind trial","volume":"58","author":"Orwoll","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0002-9378(94)90136-8","article-title":"Nafarelin therapy in endometriosis: long-term effects on bone mineral density","volume":"171","author":"Orwoll","year":"1994","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD001297-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0015-0282(00)01537-5","article-title":"Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up","volume":"74","author":"Pierce","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001297-BIB0088|cit88","first-page":"274","article-title":"Mass analysis and bone remodeling in women with pharmacological inhibition of ovarian function. Response to nasal calcitonine.","volume":"62","author":"Segura","year":"1994","journal-title":"Ginecologia y obstetricia de Mexico"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0015-0282(16)57476-7","article-title":"Prolonged gonadotrophin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone \"add-back\" therapy","volume":"63","author":"Surrey","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0090|cit90","first-page":"581","article-title":"Effects of sodium etidronate in combination with low-dose norethidrone in patients administered a long-acting GnRH agonist: a preliminary report","volume":"81","author":"Surrey","year":"1993","journal-title":"Obstetrics and Gynaecology"},{"issue":"suppl 1","key":"10.1002\/14651858.CD001297-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000052849","article-title":"Add-back therapy: extending safety and efficacy of GnRH analogues in the gynecologic patient","volume":"45","author":"Surrey","year":"1998","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(99)00636-6","article-title":"Treatment of endometriosis with a decreasing dosage of gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\"draw-back\" therapy)","volume":"73","author":"Tahara","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(97)81853-5","article-title":"Effectiveness of tibolone on hypoestrogenic symptoms incuced by goserelin treatment in patients with endometriosis","volume":"67","author":"Taskin","year":"1997","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0094|cit94","first-page":"28","article-title":"The effect of a sex steroid-thyroid hormone mixture (metharmon-F tablets) in preventing climateric symptoms during LH-RH agonist therapy","volume":"38","author":"Uemura","year":"1993","journal-title":"Japanese Journal of Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0015-0282(16)56873-3","article-title":"Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis","volume":"62","author":"Uemura","year":"1994","journal-title":"Fertility & Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599009024979","article-title":"Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis","volume":"4","author":"Ylikorkala","year":"1990","journal-title":"Gynaecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01623688","article-title":"Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist","volume":"7","author":"Zamberlan","year":"1997","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD001297-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0301-2115(98)00028-1","article-title":"Pre or post operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicentered study","volume":"79","author":"Audebert","year":"1998","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"issue":"suppl 1","key":"10.1002\/14651858.CD001297-BIB0099|cit99","first-page":"45","article-title":"Prevention and treatment of osteoporosis with hormone replacement therapy","volume":"38","author":"Christiansen","year":"1993","journal-title":"International Journal of Fertility & Menopausal Studies"},{"key":"10.1002\/14651858.CD001297-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-69-4-837","article-title":"Reduced one mass in reproductive-aged women with endometriosis","volume":"69","author":"Comite","year":"1989","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6793","key":"10.1002\/14651858.CD001297-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","article-title":"Bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"303","author":"Cundy","year":"1991","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001297-BIB0102|cit102","first-page":"410","article-title":"Bone mass in endometriosis patients treated with GnRH agonist implant or danazol","volume":"77","author":"Dodin","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001297-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0002-9378(25)90630-8","article-title":"Relationship of ectopic adenomyomata to ovarian function","volume":"10","author":"Graves","year":"1925","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1210\/jcem-72-2-510","article-title":"Bone mineral density of the lumbar spine in endometriosis subjects compared to an age-similar control population","volume":"72","author":"Lane","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jcem-65-4-697","article-title":"Bone mass and its relationship to age and the menopause","volume":"65","author":"Nilas","year":"1987","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD001297-BIB0106|cit106","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Prentice","year":"2003","journal-title":"The Cochrane Library"},{"issue":"2","key":"10.1002\/14651858.CD001297-BIB0107|cit107","article-title":"Danazol for pelvic pain associated with endometriosis (Cochrane Review)","author":"Selak","year":"2003","journal-title":"The Cochrane Library"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0889-8529(18)30352-9","article-title":"Measurements of bone mass and bone density","volume":"18","author":"Wahner","year":"1989","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD001297-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in premenopausal women","volume":"23","author":"Wells","year":"2002","journal-title":"Endocrine Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001297\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:18:17Z","timestamp":1776662297000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001297"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,10,20]]},"references-count":109,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001297","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,20]]}}}